疫苗公司Moderna（莫德纳）和美国药企默沙东宣布黑色素瘤皮肤癌疫苗Intismeran Autogene（以下简称intismeran）在大型试验中达到目标影响。 资本市场反应强烈。莫德纳当日股价大涨近177%，默沙东同步大涨近13%，整个mRNA（信使核糖核酸）板块也随之出现明显行情。 对莫德纳而言，新冠疫情相关业务消退后，癌症疫苗一直是资本市场重点关注的管线方向，本次结果提供了新冠疫苗...
Source Link疫苗公司Moderna（莫德纳）和美国药企默沙东宣布黑色素瘤皮肤癌疫苗Intismeran Autogene（以下简称intismeran）在大型试验中达到目标影响。 资本市场反应强烈。莫德纳当日股价大涨近177%，默沙东同步大涨近13%，整个mRNA（信使核糖核酸）板块也随之出现明显行情。 对莫德纳而言，新冠疫情相关业务消退后，癌症疫苗一直是资本市场重点关注的管线方向，本次结果提供了新冠疫苗...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.